Showing results (111-120 of 361) with videos related to
Sort By:
Pageof 37
BMC Cancer|May 19, 2010
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinomaTim F Greten, Alejandro Forner, Firouzeh Korangy, et al.Cancer Immunology, Immunotherapy : CII|July 1, 2018
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinomaZachary J Brown, Su Jong Yu, Bernd Heinrich, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
Necrotic tumor cell death in vivo impairs tumor-specific immune responsesJaba Gamrekelashvili, Christine Krüger, Reinhard von Wasielewski, et al.World Journal of Gastroenterology|May 24, 2006
Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinomaLars-A Ormandy, Anatol Farber, Tobias Cantz, et al.Annals of Surgery|October 16, 2020
Transplant Oncology in Primary and Metastatic Liver Tumors: Principles, Evidence, and OpportunitiesGonzalo Sapisochin, Taizo Hibi, Christian Toso, et al.Cell and Tissue Research|September 29, 2007
Stem cells in liver regeneration and therapyTobias Cantz, Michael P Manns, Michael OttStem Cells (Dayton, Ohio)|December 20, 2014
Concise review: cell therapies for hereditary metabolic liver diseases-concepts, clinical results, and future developmentsTobias Cantz, Amar Deep Sharma, Michael OttScandinavian Journal of Gastroenterology|June 23, 2011
Epidemiological trends in incidence and mortality of hepatobiliary cancers in GermanyThomas von Hahn, Sandra Ciesek, Gerd Wegener, et al.Nature Reviews. Gastroenterology & Hepatology|March 18, 2023
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatmentJosep M Llovet, Catherine E Willoughby, Amit G Singal, et al.Cancer|March 22, 2016
Population attributable fractions of risk factors for hepatocellular carcinoma in the United StatesOxana V Makarova-Rusher, Sean F Altekruse, Tim S McNeel, et al.Pageof 37